Skip to content

Pilot study of the Living with Cancer Programme

Pilot study of the Living with Cancer Programme - the SMART pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49086
Enrollment
12
Registered
2020-02-25
Start date
2020-09-14
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced cancer and family caregivers

Interventions

The online Living with Cancer programme is a community based, peer-led self-management programme designed to help patients with advanced cancer and their family caregivers gain the confidence and sk

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients 1. Advanced cancer (with no curative treatment options available) 2. WHO performance status of 0, 1 or 2 3. Acces to internet Family caregivers 1. Involved in the care for a patient with advanced cancer 2. Acces to internet Volunteers 1. Health care professionals (e.g. nurses, physicians, social workers, psychologists, chaplains) or volunteers, currently or previously involved in the care for patients with advanced cancer 2. Acces to internet

Exclusion criteria

Exclusion criteria: 1. Younger than 18 years of age 2. Patients with WHO performance status of 3 or 4 3. Unable to provide consent 4. Unable to read and speak the Dutch language

Design outcomes

Primary

MeasureTime frame
Evaluation of the content of the programme, the organisation (dates/timing), the procedures and the measurement instruments (home diary and questionnaire). And to evaluate whether video communication is suitable and acceptable for participants, concerning receiving the programme content, peer support and online information.

Secondary

MeasureTime frame
See Primary study parameter/outcome of the study

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)